Literature DB >> 20479242

Role of CaMKIIdelta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure.

Alexander Kushnir1, Jian Shan, Matthew J Betzenhauser, Steven Reiken, Andrew R Marks.   

Abstract

The force frequency relationship (FFR), first described by Bowditch 139 years ago as the observation that myocardial contractility increases proportionally with increasing heart rate, is an important mediator of enhanced cardiac output during exercise. Individuals with heart failure have defective positive FFR that impairs their cardiac function in response to stress, and the degree of positive FFR deficiency correlates with heart failure progression. We have identified a mechanism for FFR involving heart rate dependent phosphorylation of the major cardiac sarcoplasmic reticulum calcium release channel/ryanodine receptor (RyR2), at Ser2814, by calcium/calmodulin-dependent serine/threonine kinase-delta (CaMKIIdelta). Mice engineered with an RyR2-S2814A mutation have RyR2 channels that cannot be phosphorylated by CaMKIIdelta, and exhibit a blunted positive FFR. Ex vivo hearts from RyR2-S2814A mice also have blunted positive FFR, and cardiomyocytes isolated from the RyR2-S2814A mice exhibit impaired rate-dependent enhancement of cytosolic calcium levels and fractional shortening. The cardiac RyR2 macromolecular complexes isolated from murine and human failing hearts have reduced CaMKIIdelta levels. These data indicate that CaMKIIdelta phosphorylation of RyR2 plays an important role in mediating positive FFR in the heart, and that defective regulation of RyR2 by CaMKIIdelta-mediated phosphorylation is associated with the loss of positive FFR in failing hearts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20479242      PMCID: PMC2890457          DOI: 10.1073/pnas.1005843107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Heart failure and the ryanodine receptor: does Occam's razor rule?

Authors:  D A Eisner; A W Trafford
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

2.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

Review 3.  Altered cardiac myocyte Ca regulation in heart failure.

Authors:  Donald M Bers
Journal:  Physiology (Bethesda)       Date:  2006-12

4.  Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity.

Authors:  D R Witcher; R J Kovacs; H Schulman; D C Cefali; L R Jones
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

5.  Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes.

Authors:  D Hagemann; M Kuschel; T Kuramochi; W Zhu; H Cheng; R P Xiao
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

Review 6.  The multifunctional calcium/calmodulin-dependent protein kinase: from form to function.

Authors:  A P Braun; H Schulman
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

7.  Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression.

Authors:  Xander H T Wehrens; Stephan E Lehnart; Steven Reiken; John A Vest; Anetta Wronska; Andrew R Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-06       Impact factor: 11.205

8.  Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility.

Authors:  Wen Zhao; Yoshiki Uehara; Guoxiang Chu; Qiujing Song; Jiang Qian; Karen Young; Evangelia G Kranias
Journal:  J Mol Cell Cardiol       Date:  2004-08       Impact factor: 5.000

9.  Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.

Authors:  Steven Reiken; Xander H T Wehrens; John A Vest; Alessandro Barbone; Stefan Klotz; Donna Mancini; Daniel Burkhoff; Andrew R Marks
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

Review 10.  Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance.

Authors:  Masao Endoh
Journal:  Eur J Pharmacol       Date:  2004-10-01       Impact factor: 4.432

View more
  58 in total

1.  Cooperative coupling of cell-matrix and cell-cell adhesions in cardiac muscle.

Authors:  Megan L McCain; Hyungsuk Lee; Yvonne Aratyn-Schaus; André G Kléber; Kevin Kit Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-06       Impact factor: 11.205

2.  How does CaMKIIdelta phosphorylation of the cardiac ryanodine receptor contribute to inotropy?

Authors:  David A Eisner; Christopher H George; Godfrey L Smith; Andrew W Trafford; Luigi A Venetucci
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-21       Impact factor: 11.205

3.  Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice.

Authors:  Jian Shan; Alexander Kushnir; Matthew J Betzenhauser; Steven Reiken; Jingdong Li; Stephan E Lehnart; Nicolas Lindegger; Marco Mongillo; Peter J Mohler; Andrew R Marks
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

Review 4.  Mechanisms of altered Ca²⁺ handling in heart failure.

Authors:  Min Luo; Mark E Anderson
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 5.  New Insights in Cardiac Calcium Handling and Excitation-Contraction Coupling.

Authors:  Jessica Gambardella; Bruno Trimarco; Guido Iaccarino; Gaetano Santulli
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 6.  Intracellular calcium release channels: an update.

Authors:  Gaetano Santulli; Ryutaro Nakashima; Qi Yuan; Andrew R Marks
Journal:  J Physiol       Date:  2017-05-15       Impact factor: 5.182

7.  Cardiac CaV1.2 channels require β subunits for β-adrenergic-mediated modulation but not trafficking.

Authors:  Lin Yang; Alexander Katchman; Jared Kushner; Alexander Kushnir; Sergey I Zakharov; Bi-Xing Chen; Zunaira Shuja; Prakash Subramanyam; Guoxia Liu; Arianne Papa; Daniel Roybal; Geoffrey S Pitt; Henry M Colecraft; Steven O Marx
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

Review 8.  Ryanodine receptor patents.

Authors:  Alexander Kushnir; Andrew R Marks
Journal:  Recent Pat Biotechnol       Date:  2012-12

9.  Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro.

Authors:  Miriam Kalbitz; Fatemeh Fattahi; Todd J Herron; Jamison J Grailer; Lawrence Jajou; Hope Lu; Markus Huber-Lang; Firas S Zetoune; J Vidya Sarma; Sharlene M Day; Mark W Russell; José Jalife; Peter A Ward
Journal:  J Immunol       Date:  2016-08-12       Impact factor: 5.422

10.  Regulation of cardiac ATP-sensitive potassium channel surface expression by calcium/calmodulin-dependent protein kinase II.

Authors:  Ana Sierra; Zhiyong Zhu; Nicolas Sapay; Vikas Sharotri; Crystal F Kline; Elizabeth D Luczak; Ekaterina Subbotina; Asipu Sivaprasadarao; Peter M Snyder; Peter J Mohler; Mark E Anderson; Michel Vivaudou; Leonid V Zingman; Denice M Hodgson-Zingman
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.